The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Increase In Market Value Is Predicted For The Intravenous Therapy Solutions Market During The 2026–2030 Period?
The intravenous therapy solutions market has experienced significant growth recently. Its value is projected to rise from $13.17 billion in 2025 to $14.53 billion in 2026, driven by a compound annual growth rate (CAGR) of 10.3%. This historical expansion can be attributed to the development of hospital infrastructure, a growing occurrence of dehydration and electrolyte imbalance, the increasing use of IV therapy in clinics, advancements in IV solution technology, and a rise in surgical procedures.
The intravenous therapy solutions market size is projected to experience significant expansion in the coming years, with its value expected to reach $21.25 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.0%. This growth during the forecast period can be attributed to several factors such as the increasing adoption of home healthcare, the rising demand for customized nutrition and medication administration, technological integration with digital health platforms, market expansion into emerging regions, and the growing emphasis on chronic disease management. Furthermore, major trends anticipated in the forecast period include personalized IV therapy solutions, portable and home-based IV devices, enhancements in infection control and safety, advanced electrolyte and nutrient formulations, and integration with electronic health records (EHR).
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25802&type=smp
Which Major Factors Are Contributing To The Development Of The Intravenous Therapy Solutions Market?
The future expansion of the intravenous therapy solutions market is anticipated to be fueled by the increasing demand for minimally invasive therapies. These therapies are medical procedures characterized by minimal bodily penetration or incisions, frequently leading to faster recovery times and fewer complications. This rising demand stems from their effectiveness in alleviating postoperative discomfort, thereby facilitating quicker patient recuperation and enhancing comfort throughout healing. Intravenous therapy solutions complement minimally invasive treatments by facilitating the prompt and direct administration of vital fluids, medications, and nutrients into the bloodstream, which is crucial for optimal patient management and quicker healing. A notable example is the data from June 2024, where the US-based non-profit organization, the American Society of Plastic Surgeons, reported a 7% increase in minimally invasive procedures in 2023, surpassing the growth of surgical procedures by 2%. Consequently, the escalating need for minimally invasive therapies is propelling the expansion of the intravenous (IV) therapy solutions market.
How Is Segment Classification Applied In The Intravenous Therapy Solutions Market?
The intravenous therapy solutions market covered in this report is segmented –
1) By Product Type: Crystalloids, Colloids, Blood Products, Other Product Types
2) By Application: Fluid And Electrolyte Imbalance, Nutritional Support, Medication Administration, Blood Transfusion, Other Applications
3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Other End-Users
Subsegments:
1) By Crystalloids: Normal Saline (0.9% Sodium Chloride), Half Normal Saline (0.45% Sodium Chloride), Lactated Ringer’s Solution, Dextrose Solutions, Hypertonic Saline
2) By Colloids: Albumin, Dextran, Hydroxyethyl Starch (HES), Gelatin
3) By Blood Products: Packed Red Blood Cells (PRBCs), Platelets, Fresh Frozen Plasma (FFP), Cryoprecipitate
4) By Other Product Types: Intravenous Immunoglobulins (IVIG), Parenteral Nutrition Solutions, Specialty Intravenous Drugs And Additives
What Trends Are Influencing The Future Of The Intravenous Therapy Solutions Market?
Leading entities within the intravenous therapy solutions market are emphasizing the creation of advanced solutions, such as ready-to-use drug infusions, to boost treatment effectiveness and minimize preparation time in clinical environments. Ready-to-use drug infusion refers to pre-mixed, pre-labeled intravenous (IV) medications supplied in standardized doses and packaging, thereby removing the requirement for on-site compounding or dilution. For instance, in May 2024, B. Braun Medical Inc., a US-based manufacturing company, unveiled Levetiracetam in Sodium Chloride Injection, an intravenous anticonvulsant solution ready for immediate use. This product is intended for seizure management and is provided in standardized concentrations and volumes, eliminating the necessity for dilution or compounding at the point of care. The Levetiracetam IV formulation is pre-mixed in a flexible container, ensuring dosing accuracy, lessening contamination risks, and improving convenience for healthcare professionals in emergency and inpatient settings.
Who Are The Major Companies Operating In The Intravenous Therapy Solutions Market?
Major companies operating in the intravenous therapy solutions market are Pfizer Inc., Otsuka Pharmaceutical Co. Ltd., Baxter International Inc., Fresenius Kabi AG, Grifols S.A., Terumo Corporation, Dr. Reddy’s Laboratories Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Hikma Pharmaceuticals PLC, Biocon Limited, B. Braun Melsungen Aktiengesellschaft, JW Life Science Corporation, AdvaCare Pharma USA, Soxa Formulations & Research Pvt. Ltd., Vifor Pharma Management Ltd., Aetos Pharma Private Limited, LXIR Medilabs Private Limited, Amanta Healthcare Limited, Aculife Healthcare Private Limited, Claris Lifesciences Limited, Osel Lifesciences Pvt. Ltd., BBraun Avitum AG
Access The Complete Intravenous Therapy Solutions Market Report:
https://www.thebusinessresearchcompany.com/report/intravenous-therapy-solutions-global-market-report
Which Region Is The Primary Market For The Intravenous Therapy Solutions Market?
North America was the largest region in the intravenous therapy solutions market in 2025. The regions covered in the intravenous therapy solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Intravenous Therapy Solutions Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/report/intravenous-therapy-solutions-global-market-report
Browse Through More Reports Similar to the Global Intravenous Therapy Solutions Market 2026, By The Business Research Company
Preventive Healthcare Technologies And Services Market Report 2026
Endotracheal Tubes Market Report 2026
https://www.thebusinessresearchcompany.com/report/endotracheal-tubes-global-market-report
Clinical Trial Equipment And Ancillary Solutions Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model